21.01.2015 Views

2013 Prior Authorization Drug Requirements - CCHP

2013 Prior Authorization Drug Requirements - CCHP

2013 Prior Authorization Drug Requirements - CCHP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

FORMULARY<br />

DRUG<br />

BRAND NAME<br />

generic name<br />

orphenadrine<br />

compound ds tab 1<br />

orphenadrine<br />

citrate er tab 1<br />

DRUG<br />

TIER<br />

LEVEL<br />

COVERED<br />

USES<br />

<strong>CCHP</strong> Senior Select Program (HMO SNP)<br />

<strong>2013</strong> <strong>Prior</strong> <strong>Authorization</strong> <strong>Drug</strong> <strong>Requirements</strong><br />

Last Updated 04/01/<strong>2013</strong><br />

EXCLUSION<br />

CRITERIA<br />

All FDAapproved<br />

indications not<br />

otherwise<br />

excluded from<br />

Part D. N/A N/A<br />

All FDAapproved<br />

indications not<br />

otherwise<br />

excluded from<br />

Part D. N/A N/A<br />

REQUIRED<br />

MEDICAL<br />

INFORMATION<br />

AGE<br />

RESTRICTION<br />

Patients aged less<br />

than 65 years,<br />

approve. Patients<br />

aged 65 years and<br />

older, other criteria<br />

apply.<br />

N/A<br />

Patients aged less<br />

than 65 years,<br />

approve. Patients<br />

aged 65 years and<br />

older, other criteria<br />

apply.<br />

N/A<br />

PRESCRIBER<br />

RESTRICTION<br />

COVERAGE<br />

DURATION<br />

<strong>Authorization</strong><br />

will be for 1<br />

month.<br />

<strong>Authorization</strong><br />

will be for 1<br />

month.<br />

<strong>CCHP</strong> Senior Select Program (HMO SNP) is a Coordinated Care plan with a Medicare contract and a contract with the California Medicaid program.<br />

H0571_<strong>2013</strong>_142_FINAL_2 Approved 11282012<br />

146<br />

OTHER<br />

CRITERIA<br />

if the patient has<br />

tried one of the<br />

following<br />

biologic<br />

DMARDs,<br />

adalimumab,<br />

etanercept, or<br />

infliximab for at<br />

least 2 months<br />

or was intolerant<br />

to one of these<br />

therapies.<br />

Musculoskeletal<br />

conditions/disor<br />

ders, approve if<br />

the patient has<br />

tried two other<br />

therapies for the<br />

current<br />

condition.<br />

Musculoskeletal<br />

conditions/disor<br />

ders, approve if<br />

the patient has<br />

tried two other<br />

therapies for the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!